RBQM Technology Trends: Shaping the Future of Clinical Trials
In the evolving field of clinical trials, Risk-Based Quality Management (RBQM) emerges as a cornerstone for enhancing trial efficiency...
The Future of DCTs is Bright According to Big Pharma and FDA
The clinical trial industry faces a critical juncture as the dust settles from the COVID-19 pandemic. During the height...
Unlocking Clinical Trials in Africa: New Insights
The continent of Africa stands at a fascinating juncture in clinical trials, presenting a blend of untapped potential and...
Your New Guide to Validate Clinical Trial DHTs
The advent of sensor-based Digital Health Technologies (sDHTs) is transforming the landscape of clinical research and patient care. I...
FDA Needs To Release ClinicalTrials.gov Guidance Now
The 2024 Clinical Trials Transformation Initiative (CTTI) report, drawing on a broad spectrum of responses from diverse stakeholders in...
Master Protocols: FDA New Flexible Approach in Cancer Trials
Master Protocols (MPs) mark a significant evolution in the realm of clinical research, especially notable in oncology. These protocols,...
A Great Divide: Sponsors Clash With FDA on Trial Data Excess
A new study, conducted collaboratively by the Tufts Center for the Study of Drug Development (Tufts CSDD), the FDA,...
Shattering Myths FDA New Era of Diverse Healthcare Solutions
In an era marked by rapid advancements in healthcare, the importance of inclusivity and innovation in clinical trials and...
How To Safeguard Your Clinical Trial In The Era Of AI
The AI Bill of Rights, released by the White House, offers a comprehensive guide to ensuring AI’s ethical and...
DCTs and Secrets To Securing Wearables Data
Decentralized Clinical Trials (DCTs) are pioneering a shift towards a more patient-centric approach in clinical research by leveraging the...